Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/08/2003WO2003038100A1 Methods and means for producing proteins with predetermined post-translational modifications
05/08/2003WO2003038096A1 Receptor for angiogenesis inhibitor and method of screening angiogenesis inhibitor
05/08/2003WO2003038095A2 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents
05/08/2003WO2003038094A1 Regulation of human glucose transporter
05/08/2003WO2003038092A1 Method for identifying transport proteins
05/08/2003WO2003038087A1 DR5 GENE PROMOTER AND Siah-1 GENE PROMOTER
05/08/2003WO2003038077A1 Method of amplyfying hematopoietic stem cells
05/08/2003WO2003038063A2 Human secreted proteins
05/08/2003WO2003038061A2 Ehrlichia disulfide bond formation proteins and uses thereof
05/08/2003WO2003038058A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema
05/08/2003WO2003038057A2 Genetic vaccine against human immunodeficiency virus
05/08/2003WO2003038055A2 Proteins involved in regulation of adipocytes and uses related thereto
05/08/2003WO2003038054A2 Structure-based design and synthesis of fgf inhibitors and fgf modulator compounds
05/08/2003WO2003038052A2 Nucleic acid-associated proteins
05/08/2003WO2003038051A2 Method of inducing apoptosis in hyperproliferative cells
05/08/2003WO2003038041A2 Il-4 mutein proteins, antibodies, compositions, methods and uses
05/08/2003WO2003038038A2 16 human secreted proteins
05/08/2003WO2003038036A2 Rescue of gonadotropin releasing hormone receptor mutants
05/08/2003WO2003038034A2 Calcitonin-like sequence expressed by gonadotropes of the anterior pituitary
05/08/2003WO2003037933A2 Dermopharmaceutically and cosmetically active oligopeptides
05/08/2003WO2003037932A2 Human coagulation factor vii polypeptides
05/08/2003WO2003037931A2 Human angiomotin-like protein 1
05/08/2003WO2003037930A1 Novel human n-methyl-d-asparatate (nmda) glutamate receptor polypeptide and gene encoding the same
05/08/2003WO2003037929A1 Polynucleotides encoding human potassium channel polypeptides
05/08/2003WO2003037928A2 Analogs of human growth hormone-releasing hormone, their preparation and use
05/08/2003WO2003037927A1 Novel protein, its dna and use thereof
05/08/2003WO2003037926A1 Diagnosis and treatment of infectious diseases through indel-differentiated proteins
05/08/2003WO2003037925A2 Precursor silk feedstock for forming filaments
05/08/2003WO2003037924A1 Aequorin as a reporter gene in yeast
05/08/2003WO2003037923A1 Aequorin as a growth marker in yeast
05/08/2003WO2003037922A1 Analgesic antitumor peptide from scorpion and method of producing it
05/08/2003WO2003037921A1 Immunointeractive molecules and uses thereof
05/08/2003WO2003037920A2 Enzyme-deficient c3 botulinum protein species and their use to promote neuronal growth and neuronal regeneration
05/08/2003WO2003037919A2 Hiv-1 subtype isolate regulatory/accessory genes, and modifications and derivatives thereof
05/08/2003WO2003037917A1 Tumor antigen
05/08/2003WO2003037915A1 Biocompatible polymers including peptide spacer
05/08/2003WO2003037830A2 Photoactivatable composition and the use of same
05/08/2003WO2003037376A1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
05/08/2003WO2003037369A1 A rapid serological test for paratuberculosis using fluorescence polarization technology
05/08/2003WO2003037367A2 New bacterium causing poultry disease and vaccine derived thereof
05/08/2003WO2003037364A1 Interleukin-18 inducing agent
05/08/2003WO2003037363A2 Non-neurotoxic plasminogen activating factors for treating stroke
05/08/2003WO2003037361A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis
05/08/2003WO2003037325A1 Hydroxy substituted amides for the treatment of alzheimer's disease
05/08/2003WO2003037267A2 Compositions and methods for the therapy and diagnosis of lung cancer
05/08/2003WO2003037264A2 Therapeutic anti-hiv (vpr) compounds
05/08/2003WO2003037251A2 Hivgp120-induced bob/gpr15 activation
05/08/2003WO2003037248A2 Fibrin nanoparticles and uses thereof
05/08/2003WO2003037172A2 Endothelial-cell binding peptides for diagnosis and therapy
05/08/2003WO2003037164A2 Methods and compositions for the diagnosis and treatment of hematological disorders using 2777
05/08/2003WO2003037081A1 Hcv gene transgenic animal
05/08/2003WO2003037080A1 Nonhuman model animal of systemic lupus erythematosus
05/08/2003WO2003037079A1 NONHUMAN MODEL ANIMAL OF Th2-MEDIATED HYPERIMMUNE RESPONSE
05/08/2003WO2003037060A2 Compositions and methods for wt1 specific immunotherapy
05/08/2003WO2003028001A8 Method and pharmaceutical composition for inducing cancer cell-specific apoptosis by combination with tnf family proteins and flavopiridol
05/08/2003WO2003025187A3 Improvement of gene expression in vectors
05/08/2003WO2003025138A3 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
05/08/2003WO2003014322A3 Proteins associated with cell growth, differentiation, and death
05/08/2003WO2003012105A3 Vegf isoform
05/08/2003WO2003006649A3 Expression system
05/08/2003WO2003006067A3 Composition comprising a parvovirus vp1-variant and a parvovirus ns1 protein for induction of cytolysis
05/08/2003WO2003005955A3 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus
05/08/2003WO2003004691A3 Regulators of biofilm formation and uses thereof
05/08/2003WO2003004687A8 Novel proteins and nucleic acids encoding same
05/08/2003WO2003004617A8 Novel human proteins, polynucleotides encoding them and methods of using the same
05/08/2003WO2003000027A3 Blocking peptide for inflammatory cell secretion
05/08/2003WO2002102767A3 Bot1: target for antifungal agents
05/08/2003WO2002100891A3 Proteins derived from non-typable haemophilus influenzae (nthi) strain
05/08/2003WO2002098908A3 Osteoclastogenesis inhibitory factor, sequence coding for it and uses
05/08/2003WO2002098368A3 Mutant forms of cholera holotoxin as an adjuvant
05/08/2003WO2002092624A3 G-protein coupled receptor
05/08/2003WO2002090974A3 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
05/08/2003WO2002088171A3 Combinatorial libraries of monomer domains
05/08/2003WO2002088168A3 Codon-optimised nucleic acid coding for apoaequorin and uses thereof
05/08/2003WO2002081499A3 Somatostatin agonists
05/08/2003WO2002079230A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
05/08/2003WO2002079222A3 Fusion proteins for specific treatment of cancer and auto-immune diseases
05/08/2003WO2002072847A3 Process for production of polypeptides
05/08/2003WO2002072608A3 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS
05/08/2003WO2002057299A3 Vegfr-3 binding peptides and their use for inhibiting angiogenesis
05/08/2003WO2002048335A3 Metal resistant plants and use for phytoremediation
05/08/2003WO2002046222A3 Compositions and methods for diagnosing alzheimer's disease
05/08/2003WO2002042467A3 Aspergillus fumigatus profilin
05/08/2003WO2002040679A3 Corynebacterium glutamicum promoters
05/08/2003WO2002034929A9 Expression vectors and uses thereof
05/08/2003WO2002024929A3 A SOLUBLE BETA 2 MICROGLOBULIN (β2M)/HFE MONOCHAIN FOR BIOTECHNOLOGICAL AND THERAPEUTIC APPLICATIONS
05/08/2003WO2002020768A9 Caveolin peptides and their use as therapeutics
05/08/2003WO2002010216A3 Proteins and nucleic acids encoding same
05/08/2003WO2001088133A3 Human semaphorin homologs and polynucleotides encoding the same
05/08/2003WO2001081378A3 G-protein coupled receptors
05/08/2003WO2001057274A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart
05/08/2003WO2000042183A3 Tumor marker zsig62
05/08/2003WO1999009179A3 Antigen constructs useful in the detection and differentiation of antibodies to hiv
05/08/2003WO1998055635A9 Methods of assaying receptor activity and constructs useful in such methods
05/08/2003US20030088890 Novel ecdysone receptors and methods for their use
05/08/2003US20030088887 Transforming plants with genes that enhance disease resistance.
05/08/2003US20030088884 Orphan leucine-repeat-containing, G protein-coupled receptors; prevention or induction of labor, treatment scleroderma, cryptorchidism, and diagnosis of a genetic condition associated LGR8 or LGR7
05/08/2003US20030088881 Protection of proteins (e.g. fibrinogen) expressed in milk from transgenic animals by co-expression of a serine proteinase inhibitor (e.g. alpha 1-antitrypsin) in the milk of the transgenic animals.
05/08/2003US20030088087 Purification of preferential nucleotide sequences; obtain nucleotide sequences, load onto column, elute, deprotect, load deprotected mixture onto column, elute and recover sequences
05/08/2003US20030088086 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of infection
1 ... 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 ... 2916